Diagnostic Challenges: From Atypical Ductal Hyperplasia to Ductal Carcinoma In Situ

This track focuses on the diagnostic challenges encountered in the spectrum of breast lesions, specifically from atypical ductal hyperplasia (ADH) to ductal carcinoma in situ (DCIS). With the increasing use of and detection techniques, the identification and accurate diagnosis of these lesions have become crucial for appropriate patient management. This track explores the complexities involved in distinguishing between ADH and DCIS, discussing the overlapping morphological features, immunohistochemical markers, and molecular characteristics that aid in differential diagnosis. The track also highlights the latest advancements in diagnostic tools, including genomic profiling and molecular testing, aiming to enhance diagnostic accuracy and guide optimal treatment strategies for patients with ADH and DCIS.

  • Histopathological Evaluation: Morphological Criteria and Interpretation Challenges
  • Radiological-Pathological Correlation: Enhancing Diagnostic Accuracy
  • Biomarkers and Molecular Profiling: Identifying High-Risk Lesions
  • Management Dilemmas: Overdiagnosis and Overtreatment
  • Emerging Techniques and Technologies: Improving Diagnostic Precision

Related Conference of Diagnostic Challenges: From Atypical Ductal Hyperplasia to Ductal Carcinoma In Situ

June 10-11, 2024

8th Global Meeting on Oncology and Radiology

Barcelona, Spain
July 11-12, 2024

24th World Congress on Cancer and Diagnostics

Vancouver, Canada
July 18-19, 2024

14th World Congress on Breast Cancer

Paris, France
September 16-17, 2024

9th World Conference on Breast and Cervical Cancer

London, UK
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France
November 24-25, 2024

7th International Conference on Anti-Cancer Drugs

Vancouver, Canada

Diagnostic Challenges: From Atypical Ductal Hyperplasia to Ductal Carcinoma In Situ Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in